No connection

Search Results

ARBE vs HIT

ARBE
Arbe Robotics Ltd.
BEARISH
Price
$0.76
Market Cap
$92.8M
Sector
Technology
AI Confidence
85%
HIT
Health In Tech, Inc.
BEARISH
Price
$1.34
Market Cap
$87.8M
Sector
Technology
AI Confidence
85%

Valuation

P/E Ratio
ARBE
--
HIT
67.0
Forward P/E
ARBE
-3.79
HIT
7.24
P/B Ratio
ARBE
2.09
HIT
4.51
P/S Ratio
ARBE
90.41
HIT
2.64
EV/EBITDA
ARBE
-1.42
HIT
29.98

Profitability

Gross Margin
ARBE
-78.17%
HIT
62.82%
Operating Margin
ARBE
-2528.82%
HIT
-2.27%
Profit Margin
ARBE
0.0%
HIT
3.84%
ROE
ARBE
-142.69%
HIT
8.45%
ROA
ARBE
-44.25%
HIT
4.92%

Growth

Revenue Growth
ARBE
362.6%
HIT
53.1%
Earnings Growth
ARBE
--
HIT
--

Financial Health

Debt/Equity
ARBE
0.65
HIT
0.01
Current Ratio
ARBE
2.21
HIT
3.13
Quick Ratio
ARBE
1.39
HIT
2.31

Dividends

Dividend Yield
ARBE
--
HIT
--
Payout Ratio
ARBE
0.0%
HIT
0.0%

AI Verdict

ARBE BEARISH

ARBE exhibits severe financial distress despite strong revenue growth, as reflected in its Piotroski F-Score of 1/9 (indicating poor financial health) and the absence of an Altman Z-Score (raising bankruptcy risk concerns). The company reports massive losses, negative margins across all metrics, and a negative ROE of -142.69%, signaling deep operational inefficiency. While revenue growth is impressive at 362.6% YoY, this is not translating into profitability or cash flow. The stock trades at an extreme Price/Sales of 90.41, far above peers and historical norms, suggesting significant overvaluation. Analysts rate it 'strong_buy' with a target of $2.25, but this is not supported by fundamentals.

Strengths
Exceptional revenue growth of 362.6% YoY
High analyst consensus with 'strong_buy' rating from 3 analysts
Positive recent earnings surprises in some quarters (e.g., +40.0% in Q1 2024)
Risks
Piotroski F-Score of 1/9 indicates extreme financial distress and poor operational health
Negative operating margin (-2528.82%) and gross margin (-78.17%) reflect severe cost inefficiencies
Negative ROE (-142.69%) and ROA (-44.25%) signal capital destruction
HIT BEARISH

HIT presents a high-risk profile characterized by a Piotroski F-Score of 4/9 (Stable) but severe technical deterioration. While the company exhibits strong revenue growth (53.10%) and an exceptionally clean balance sheet (Debt/Equity 0.01), it is trading at a massive premium to its Graham Number ($0.37) and Intrinsic Value ($0.14). The stock is currently in a freefall with a 0/100 technical trend and a 60.8% decline over the last six months, coupled with a poor earnings track record of 0/4 beats.

Strengths
Strong YoY and Q/Q revenue growth of ~53%
Negligible debt levels (Debt/Equity 0.01)
Robust liquidity with a Current Ratio of 3.13
Risks
Severe bearish technical trend (0/100 score)
Significant overvaluation relative to Graham and Intrinsic values
Negative operating margin (-2.28%) indicating operational inefficiency

Compare Another Pair

ARBE vs HIT: Head-to-Head Comparison

This page compares Arbe Robotics Ltd. (ARBE) and Health In Tech, Inc. (HIT) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.

Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.

Home
Terminal
AI
Markets
Profile